Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Pierre Delord

Showing results (31-40 of 178) with videos related to

Pageof 18
Sort By:
Cancer Chemotherapy and Pharmacology|March 21, 2003
Population pharmacokinetics of oxaliplatinJean-Pierre Delord, Amine Umlil, Rosine Guimbaud, et al.
Oncology|January 12, 2008
A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancerJean Pierre Delord, Florence Dalenc, Frédéric Pinguet, et al.
Journal of Ovarian Research|April 18, 2014
Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progressionLaetitia Picaud, Benoît Thibault, Eliane Mery, et al.
Investigational New Drugs|February 12, 2013
Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neckJean-Pascal Machiels, Marie-Christine Kaminsky, Ulrich Keller, et al.
Computers in Biology and Medicine|October 28, 2017
Comparison of variable selection methods for high-dimensional survival data with competing eventsJulia Gilhodes, Christophe Zemmour, Soufiane Ajana, et al.
British Journal of Cancer|January 17, 2018
Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2Rastislav Bahleda, Andrea Varga, Yann Bergé, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Design and Mechanism of Action of a New Prototype of Combi-Molecule "Programed" to Release Bioactive Species at a pH Range Akin to That of the Tumor MicroenvironmentAnne-Laure Larroque-Lombard, Etienne Chatelut, Jean-Pierre Delord, et al.
Clinical Lung Cancer|April 24, 2016
Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the LungMony Ung, Isabelle Rouquette, Thomas Filleron, et al.
Head & Neck|July 14, 2012
Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinomaFabienne Thomas, Paul Delmar, Sébastien Vergez, et al.
BMJ Open|January 30, 2023
Study protocol of the CREDO randomised controlled trial: evaluation of a structured return home consultation for patients suffering from metastaticcancerLaëtitia Gimenez, Pascale Grosclaude, Vladimir Druel, et al.
Pageof 18

Showing results (31-40 of 178) with videos related to

Sort By:
Pageof 18
Cancer Chemotherapy and Pharmacology|March 21, 2003
Population pharmacokinetics of oxaliplatinJean-Pierre Delord, Amine Umlil, Rosine Guimbaud, et al.
Oncology|January 12, 2008
A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancerJean Pierre Delord, Florence Dalenc, Frédéric Pinguet, et al.
Journal of Ovarian Research|April 18, 2014
Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progressionLaetitia Picaud, Benoît Thibault, Eliane Mery, et al.
Investigational New Drugs|February 12, 2013
Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neckJean-Pascal Machiels, Marie-Christine Kaminsky, Ulrich Keller, et al.
Computers in Biology and Medicine|October 28, 2017
Comparison of variable selection methods for high-dimensional survival data with competing eventsJulia Gilhodes, Christophe Zemmour, Soufiane Ajana, et al.
British Journal of Cancer|January 17, 2018
Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2Rastislav Bahleda, Andrea Varga, Yann Bergé, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Design and Mechanism of Action of a New Prototype of Combi-Molecule "Programed" to Release Bioactive Species at a pH Range Akin to That of the Tumor MicroenvironmentAnne-Laure Larroque-Lombard, Etienne Chatelut, Jean-Pierre Delord, et al.
Clinical Lung Cancer|April 24, 2016
Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the LungMony Ung, Isabelle Rouquette, Thomas Filleron, et al.
Head & Neck|July 14, 2012
Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinomaFabienne Thomas, Paul Delmar, Sébastien Vergez, et al.
BMJ Open|January 30, 2023
Study protocol of the CREDO randomised controlled trial: evaluation of a structured return home consultation for patients suffering from metastaticcancerLaëtitia Gimenez, Pascale Grosclaude, Vladimir Druel, et al.
Pageof 18